| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 684667 | Null | 0.0105972823829604 | 0.68250295 |
| NSC 692347 | Null | 0.0105972823829604 | 0.12661882 |
| NSC 697726 | RH1 | 0.0105972823829604 | 0.63766509 |
| NSC 698792 | 1H-Naphth[2',1':4,5]indeno[2,1-b]furan,.beta.-D-glucopyranoside derivative | 0.0105972823829604 | -0.013375168 |
| NSC 699490 | Doxoform | 0.0105972823829604 | 0.67202518 |
| NSC 702323 | Null | 0.0105972823829604 | 0.10758099 |
| NSC 708046 | Null | 0.0105972823829604 | 0.090112083 |
| NSC 708048 | 2-Butenoic acid, 4,4-dicyano-4-[[(3-thienyl)methylene]amino]-, ethyl ester, (2Z,1E)- | 0.0105972823829604 | 0.091504178 |
| NSC 70931 | 2-Picenecarboxylic acid, 1,2,3,4,4a,5,6,6a,11,12b,13,14,14a,14b-tetradecahydro-10-hydroxy-2,4a,6a,9,12b,14a-hexamethyl-11-oxo- | 0.0105972823829604 | -0.1019517 |
| NSC 709362 | Acetamide, N,N'-(1,5-pentanediyl)bis[2-(1,3,5,11a-tetrahydro- 5-oxopyrrolo[2,1-c][1,4]benzodiazepin-2-ylidene)- | 0.0105972823829604 | 0.16271391 |